Pathway for patients with suspected Upper GI (OG) Cancer

Slides:



Advertisements
Similar presentations
Karen Pocock Skin Cancer Clinical Nurse Specialist
Advertisements

A Case Study GP Masterclass Catherine Dale, RN, BSc Cancer Care
62 day performance John Wayman North Cumbria. 62 Day performance 2012 (Upper GI)
Cancer of Unknown Primary Dr Chris Jones Consultant Medical Oncologist North of England Cancer Network Annual Conference 20 September 2013.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Managing the patients experience of radical surgery with HIPEC for stage 4 colorectal disease Jackie Rodger Lead Colorectal Nurse Specialist Carol Baird.
Acute Oncology Service (AOS) Monday – Friday 8am – 4pm Bleep: 946 T: x5726 F: Dr Nicola Beech Dr Jillian Noble Dr Susannah.
Breast cancer patient pathway
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Organized Diagnostic Assessment Demonstration Projects Organized Diagnostic Assessment Demonstration Projects Grand River Regional Diagnostic Assessment.
Acute Oncology Dr Nicola Storey.
The Good, The Bad and The Patient Choice! Colorectal Patient Pathways Across the Network Presented by: Teresa Coombes Cancer, Oncology, Haematology and.
‘Let’s get it right - Referral for suspected Cancer’
Gynaecology MDT Coordinator
RESULTSOF UPPER GI MDT QUESTIONNAIRE Sukhbir Ubhi National Clinical Lead for Upper GI Cancer Services Collaborative 'Improvement Partnership'
Summary The National Clinical Pathway represents a pathway that is achievable now, requiring no extra resources but reliant on appropriate logistics. The.
RCR Bladder Cancer Radiotherapy Audit 2016
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
National Optimal Clinical Pathway for suspected and confirmed lung cancer: Referral to treatment Note: this was previously circulated for discussion as.
NICE GUIDELINES February 2016
National Clinical Pathway for suspected and confirmed lung cancer:
See in clinic and assess/ CA19-9
WiFi name: WifiLoveMCR Password: internet Join the conversation on Twitter using #DrivingChange
2 November John Childs and Deborah Woodley
Walking alongside you, against the tide
Oesophago–Gastric Cancer Audit
Challenges of Rare Cancers…
Upper Gastrointestinal Cancers Top ⑩ Tips
Camden Two Week Wait Referrals Feedback
Oesophago–Gastric Cancer
Velindre NHS Trust June 10th 2011
National Oesophago–Gastric Cancer Audit 2015.
Upper GI Cancer and Rehabilitation
The effect of neo-adjuvant chemotherapy on the discrepancy between the endoscopic ultrasonography (EUS) and pathological staging of oesophageal cancer.
Paediatric Orthopaedic MSK Pathways Pamela Holland
NICE Guidance – Service delivery for patients with Sarcomas
Oesophago–Gastric Cancer
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
Dorset County Hospital Cancer of Unknown Primary (CUP) Service
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
Oesophago–Gastric Cancer
Pathway for patients with suspected Breast Cancer
Six stage journey When diagnosed with a brain tumour.
Katie’s story: Advanced colorectal cancer
Cancer Waiting Times Standards
The Single Cancer Pathway
Management of Vulval Melanoma
Pathway for patients with suspected Skin Cancer
Neuro Oncology Therapy Update
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Inquiry into geographical inequalities in breast cancer
Early Diagnosis Diagnostics Cancer Waits Survivorship South West Cancer Network 14 November 2014.
Pathway for patients with suspected colorectal cancer
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
A systemwide approach to reducing long waiters
Worcestershire Colorectal Cancer 2ww Pathway
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Pathway for patients with suspected HPB Cancer Inter Provider Transfer
Impact of 2019 Sarcoma Service specification for Bristol
Upper GI SSG Meeting Statistics
Early and locally advanced breast cancer
Pathway for patients with suspected Breast Cancer
28 Day Faster Diagnosis Standard
Living Well With and Beyond Cancer
Airedale NHS Foundation Trust
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Calderdale and Huddersfield NHS Foundation Trust
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
Presentation transcript:

Pathway for patients with suspected Upper GI (OG) Cancer Maximum Wait (Days) Provide information and psychological support throughout the pathway GP to ensure that patient stops PPI’s 2 weeks in advance Referral received in secondary care 14 Days History Physical examination WHO performance status Endoscopy & biopsy CT First Seen Rapid specialist assessment & one stop diagnostic service 14 Allocate UGI CNS Holistic assessment Is UGI cancer or HGD confirmed or suspected? Consider rehabilitation needs No Patient removed from cancer pathway 16-18 years old – refer to Paediatric Oncology (GNCC) for treatment and TYA MDT for discussion 19-24 years old – continue on tumour site specific pathway & refer to TYA MDT for discussion. See TYA pathway Yes Inform patient’s GP Local MDT discussion with Specialist MDT See OG rehabilitation care pathway liaise & involve healthcare professionals as required 17 Days Further diagnostic / staging investigations as appropriate Refer for PET scan if indicated Inter Provider Transfer Network Best Practice Specialist MDT discuss treatment & rehabilitation plan plus consideration for clinical trials 31 18 Days Laparoscopy EUS PET Scan MRI Assess fitness Bone Scan Decision to treat Staging investigations as indicated 49 13 Days Agree proposed treatment plan with patient Surgery Radiotherapy Chemo Radiotherapy Endoscopic treatment Neo Adjuvant Surgery First treatment HER2 testing for gastric & junctional tumours 62 Supportive & palliative care Radical treatment Earliest Clinically Appropriate Date for commencement of subsequent treatment Is further treatment required Yes No Appropriate after care UGI Cancer Pathway [Final]